No Data
No Data
Piper Sandler Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $95
Piper Sandler Sticks to Their Buy Rating for Boston Scientific (BSX)
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
December Starts With a Mixed Market | Live Stock
Boston Scientific Corporation's (NYSE:BSX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
10 Health Care Stocks With Whale Alerts In Today's Session